Efficacy of CDK 4/6 inhibition after fulvestrant in metastatic breast cancer. (April 2018) - Hoste, G.; Punie, K.; Wildiers, H.; Neven, P.; Vergote, I.; Beuselinck, B.; Concin, N.; Han, S.; Van Nieuwenhuysen, E.; Salihi, R.; Smeets, A.; Berteloot, P.; et al.